TY - JOUR
T1 - Annual report of the Japanese Breast Cancer Society registry for 2016
AU - Kubo, Makoto
AU - Kumamaru, Hiraku
AU - Isozumi, Urara
AU - Miyashita, Minoru
AU - Nagahashi, Masayuki
AU - Kadoya, Takayuki
AU - Kojima, Yasuyuki
AU - Aogi, Kenjiro
AU - Hayashi, Naoki
AU - Tamura, Kenji
AU - Asaga, Sota
AU - Niikura, Naoki
AU - Ogo, Etsuyo
AU - Iijima, Kotaro
AU - Tanakura, Kenta
AU - Yoshida, Masayuki
AU - Miyata, Hiroaki
AU - Yamamoto, Yutaka
AU - Imoto, Shigeru
AU - Jinno, Hiromitsu
N1 - Funding Information:
This work was funded by the Registration Committee of the Japanese Breast Cancer Society and the Japan Society for the Promotion of Science KAKENHI (Grant No. 18K08577). Acknowledgements
Funding Information:
The authors thank all the affiliated institutes participating in the Breast Cancer Registry of the JBCS for their efforts to register the patients’ data. Also, we thank James P. Mahaffey, PhD, from Edanz Group (www.edanzediting.com/ac) for his support in English editing the draft of this manuscript.
Publisher Copyright:
© 2020, The Author(s).
PY - 2020/7/1
Y1 - 2020/7/1
N2 - The Japanese Breast Cancer Society (JBCS) registry began data collection in 1975, and it was integrated into National Clinical Database in 2012. As of 2016, the JBCS registry contains records of 656,896 breast cancer patients from more than 1400 hospitals throughout Japan. In the 2016 registration, the number of institutes involved was 1422, and the total number of patients was 95,870. We herein present the summary of the annual data of the JBCS registry collected in 2016. We analyzed the demographic and clinicopathologic characteristics of registered breast cancer patients from various angles. Especially, we examined the registrations on family history, menstruation, onset age, body mass index according to age, nodal status based on tumor size and subtype, and proportion based on ER, PgR, and HER2 status. This report based on the JBCS registry would support clinical management for breast cancer patients and clinical study in the near future.
AB - The Japanese Breast Cancer Society (JBCS) registry began data collection in 1975, and it was integrated into National Clinical Database in 2012. As of 2016, the JBCS registry contains records of 656,896 breast cancer patients from more than 1400 hospitals throughout Japan. In the 2016 registration, the number of institutes involved was 1422, and the total number of patients was 95,870. We herein present the summary of the annual data of the JBCS registry collected in 2016. We analyzed the demographic and clinicopathologic characteristics of registered breast cancer patients from various angles. Especially, we examined the registrations on family history, menstruation, onset age, body mass index according to age, nodal status based on tumor size and subtype, and proportion based on ER, PgR, and HER2 status. This report based on the JBCS registry would support clinical management for breast cancer patients and clinical study in the near future.
UR - http://www.scopus.com/inward/record.url?scp=85084483604&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85084483604&partnerID=8YFLogxK
U2 - 10.1007/s12282-020-01081-4
DO - 10.1007/s12282-020-01081-4
M3 - Article
C2 - 32394414
AN - SCOPUS:85084483604
SN - 1340-6868
VL - 27
SP - 511
EP - 518
JO - Breast Cancer
JF - Breast Cancer
IS - 4
ER -
